Prescription of psychotropic medication to people with intellectual disabilities in primary health care settings
By: Molyneux, Philip.
Contributor(s): Emerson, Eric | Caine, Amanda.
Series: Journal of Applied Research in Intellectual Disabilities 12 (1) 1999: 46-57. 1999Content type: text Media type: unmediated Carrier type: volume Subject(s): MEDICATION | DRUG THERAPY
| RESEARCHSummary: The prescription of psychotropic drugs to people with intellectual disabilities was examined in 357 people with intellectual disabilities served by 57 GP's. The results of the survey indicated thatSummary: (1) 21% of adults with intellectual disabilities were receiving neuroleptic medication.Summary: (2) The likelihood of an adult being prescribed neuropleptic medication was associated with a number of factors including whether they had been resettled from long-stay hospital and whether they were under review by a consultant psychiatrist.Summary: (3) The likelihood of an adult being prescribed anti-depression medication was associated whether they were under review by a consultation psychiatrist and whether they had a recorded mental health problem.Summary: (4). The likelihood of an adult being prescribed abxiolytic/hypnotic medication was associated with a different set of factors including whether they had significant support needs, whether they had epilepsy and wether they were under review by a consultant psychiatrist.Summary: (5) Nearly one-half of people with intellectual disabilities who are receiving neuroleptic medication and just over one-third of people with intellectual disabilities who are receiving anti-depressant medication are not under the review of a consultant psychiatrist.Summary: (6) The factors predicating prescribing practices of the GPs in such cases were broadly consistent with the factors predicating overall prescribing practices. [AJ].
| Item type | Current library | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|
| Article Research | IHC Library | Article (Browse shelf(Opens below)) | Available (Article available on request) | 11057 |
The prescription of psychotropic drugs to people with intellectual disabilities was examined in 357 people with intellectual disabilities served by 57 GP's. The results of the survey indicated that
(1) 21% of adults with intellectual disabilities were receiving neuroleptic medication.
(2) The likelihood of an adult being prescribed neuropleptic medication was associated with a number of factors including whether they had been resettled from long-stay hospital and whether they were under review by a consultant psychiatrist.
(3) The likelihood of an adult being prescribed anti-depression medication was associated whether they were under review by a consultation psychiatrist and whether they had a recorded mental health problem.
(4). The likelihood of an adult being prescribed abxiolytic/hypnotic medication was associated with a different set of factors including whether they had significant support needs, whether they had epilepsy and wether they were under review by a consultant psychiatrist.
(5) Nearly one-half of people with intellectual disabilities who are receiving neuroleptic medication and just over one-third of people with intellectual disabilities who are receiving anti-depressant medication are not under the review of a consultant psychiatrist.
(6) The factors predicating prescribing practices of the GPs in such cases were broadly consistent with the factors predicating overall prescribing practices. [AJ].
There are no comments on this title.
